Sponsor

Hanyang University Seoul Hospital

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Hanyang University Seoul Hospital appears in 5 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials5
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

5 shown
Long-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 MutationsNCT06429644 · lead sponsor · 2022-07-07
COMPLETED
Vortioxetine for Treatment of Depressive Mood and Alcohol UseNCT04498897 · lead sponsor · 2019-01-25
UNKNOWN
Fimasartan/Amlodipine Combination Phase IIINCT02152306 · collaborator · 2014-04-01
COMPLETED
A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential HypertensionNCT01518998 · collaborator · 2011-08-01
COMPLETED
Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) PatientsNCT01312363 · collaborator · 2009-06-01
COMPLETED

Sponsor roles

collaborator3
lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.